Skip Nav Destination
Issues
15 March 2012
-
Cover Image
Cover Image
![issue cover]()
IGFBP-5 may be an important regulator of IGF signaling in breast cancer cells. Distribution of IGFBP-5 in MCF-7 cells is shown by immunofluorescence analysis using confocal microscopy. IGFBP-5 is shown in red and nuclei are shown in blue (DAPI). For details, see the article by Becker and colleagues on page 1808 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Perspectives in Drug Approval
Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a “Physician's Choice” Control Arm in a Randomized Approval Trial
Martha Donoghue; Steven J. Lemery; Weishi Yuan; Kun He; Rajeshwari Sridhara; Stacy Shord; Hong Zhao; Anshu Marathe; Lori Kotch; Josephine Jee; Ying Wang; Liang Zhou; William M. Adams; Vaishali Jarral; Anne Pilaro; Richard Lostritto; Joseph E. Gootenberg; Patricia Keegan; Richard Pazdur
Molecular Pathways
CCR Focus
Review
Human Cancer Biology
Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
Chien-Feng Li; Ju-Ming Wang; Hong-Yo Kang; Chiung-Kuei Huang; Jun-Wen Wang; Fu-Min Fang; Yu-Hui Wang; Wen-Ren Wu; Shau-Hsuan Li; Shih-Chen Yu; Jen-Chieh Lee; Jui Lan; Yow-Ling Shiue; Li-Ching Wu; Hsuan-Ying Huang
Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers
Gerwin Heller; Marlene Weinzierl; Christian Noll; Valerie Babinsky; Barbara Ziegler; Corinna Altenberger; Christoph Minichsdorfer; György Lang; Balazs Döme; Adelheid End-Pfützenreuter; Britt-Madeleine Arns; Yuliya Grin; Walter Klepetko; Christoph C. Zielinski; Sabine Zöchbauer-Müller
Cancer Therapy: Preclinical
Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis
Osamu Takahashi; Ritsuko Komaki; Paul D. Smith; Juliane M. Jürgensmeier; Anderson Ryan; B. Nebiyou Bekele; Ignacio I. Wistuba; Jörg J. Jacoby; Maria V. Korshunova; Anna Biernacka; Baruch Erez; Keiko Hosho; Roy S. Herbst; Michael S. O'Reilly
Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor–Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer
Wei Wang; Qi Li; Shinji Takeuchi; Tadaaki Yamada; Hitomi Koizumi; Takahiro Nakamura; Kunio Matsumoto; Naofumi Mukaida; Yasuhiko Nishioka; Saburo Sone; Takayuki Nakagawa; Toshimitsu Uenaka; Seiji Yano
Imaging, Diagnosis, Prognosis
Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women
Nicolas Servant; Marc A. Bollet; Hans Halfwerk; Kevin Bleakley; Bas Kreike; Laurent Jacob; Daoud Sie; Ron M. Kerkhoven; Philippe Hupé; Rim Hadhri; Alain Fourquet; Harry Bartelink; Emmanuel Barillot; Brigitte Sigal-Zafrani; Marc J. van de Vijver
Cancer Therapy: Clinical
A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
Shivaani Kummar; Jiuping Ji; Robert Morgan; Heinz-Josef Lenz; Shannon L. Puhalla; Chandra P. Belani; David R. Gandara; Deborah Allen; Brian Kiesel; Jan H. Beumer; Edward M. Newman; Larry Rubinstein; Alice Chen; Yiping Zhang; Lihua Wang; Robert J. Kinders; Ralph E. Parchment; Joseph E. Tomaszewski; James H. Doroshow
Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
Nicolas Isambert; Gilles Freyer; Sylvie Zanetta; Benoît You; Pierre Fumoleau; Claire Falandry; Laure Favier; Sylvie Assadourian; Karen Soussan-Lazard; Samira Ziti-Ljajic; Veronique Trillet-Lenoir
Predictive Biomarkers and Personalized Medicine
KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors
Claudia Miranda; Martina Nucifora; Francesca Molinari; Elena Conca; Maria Chiara Anania; Andrea Bordoni; Piercarlo Saletti; Luca Mazzucchelli; Silvana Pilotti; Marco A. Pierotti; Elena Tamborini; Angela Greco; Milo Frattini
PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Funda Meric-Bernstam; Argun Akcakanat; Huiqin Chen; Kim-Anh Do; Takafumi Sangai; Farrell Adkins; Ana Maria Gonzalez-Angulo; Asif Rashid; Katherine Crosby; Mei Dong; Alexandria T. Phan; Robert A. Wolff; Sanjay Gupta; Gordon B. Mills; James Yao
Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
Quynh-Thu Le; Richard Fisher; Kelly S. Oliner; Richard J. Young; Hongbin Cao; Christina Kong; Edward Graves; Rodney J. Hicks; Grant A. McArthur; Lester Peters; Brian O'Sullivan; Amato Giaccia; Danny Rischin
Retraction
Advertisement
